Brant Point Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-25,000
Closed -$934K – 151
2025
Q4
$934K Sell
25,000
-25,000
-50% -$1.02M 0.11% 122
2025
Q3
$2.02M Sell
50,000
-35,455
-41% -$1.17M 0.22% 92
2025
Q2
$2.18M Sell
85,455
-18,269
-18% -$398K 0.23% 84
2025
Q1
$2.22M Buy
+103,724
New +$2.32M 0.26% 91

Other funds holding PAHC

Brant Point Investment Management's PAHC Position: Q1 2026 in Review

Brant Point Investment Management sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 25,000 shares — an estimated $934K sold.

Brant Point Investment Management first reported a position in PAHC in Q1 2025 and held it in 4 quarters. The position peaked at $2.22M in Q1 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Brant Point Investment Management reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • Brant Point Investment Management sold 25,000 Phibro Animal Health shares in Q1 2026, an estimated $934K.
  • Brant Point Investment Management first reported a position in Phibro Animal Health in Q1 2025 and held it in 4 quarters.
  • Brant Point Investment Management's Phibro Animal Health position peaked at $2.22M in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Brant Point Investment Management's 13F filing for Q1 2026, filed 14 May 2026.